pneumonia
remain
lead
caus
hospitalis
death
among
children
worldwid
nearli
million
new
case
one
million
death
annual
mostli
among
children
age
although
greatest
diseas
burden
develop
countri
pneumonia
remain
import
public
health
concern
develop
countri
concern
compound
grow
antibiot
resist
replac
diseas
caus
vaccineescap
strain
emerg
newli
identifi
australia
two
eight
pneumonia
hospitalis
per
childyear
among
children
year
old
aborigin
children
higher
risk
nonaborigin
global
bacteria
particularli
streptococcu
pneumonia
encapsul
nonencapsul
strain
haemophilu
influenza
consid
primari
caus
pneumonia
young
recent
year
increas
focu
role
respiratori
virus
childhood
pneumonia
partli
due
reduct
bacteri
diseas
associ
conjug
pneumococc
hib
vaccin
increas
capac
detect
viru
molecular
diagnost
method
sensit
techniqu
enabl
detect
virus
respiratori
specimen
children
mani
commonli
detect
respiratori
virus
bacteria
also
detect
nasopharynx
appar
healthi
children
obscur
exact
contribut
childhood
except
influenza
vaccin
licens
vaccin
common
respiratori
virus
current
avail
although
number
vaccin
respiratori
virus
clinic
date
pneumonia
aetiolog
studi
highincom
set
seek
quantifi
exact
contribut
pathogen
pneumonia
includ
healthi
wellcontrol
epidemiolog
studi
report
contribut
respiratori
virus
childhood
pneumonia
develop
set
find
unlik
generalis
set
better
develop
health
infrastructur
includ
better
vaccin
conduct
prospect
studi
estim
contribut
respiratori
virus
bacteria
childhood
pneumonia
west
australian
wa
children
highli
vaccin
highincom
popul
case
children
age
year
old
present
communityacquir
pneumonia
cap
princess
margaret
hospit
pmh
tertiari
paediatr
hospit
state
western
australia
popul
wa
children
highli
vaccin
pneumococc
conjug
vaccin
pcv
fund
nation
immunis
programm
coverag
among
infant
season
influenza
vaccin
also
fund
wa
children
age
month
year
older
children
highrisk
diagnosi
cap
requir
presenc
acut
respiratori
symptom
without
fever
evid
infiltr
consolid
chest
pragmat
definit
radiolog
confirm
pneumonia
infiltr
alveolar
consolid
determin
treat
clinician
facilit
recruit
hour
ie
radiologist
avail
review
chest
xray
equal
number
contemporan
healthi
control
attend
hospit
outpati
orthopaed
allergi
clinic
larg
urban
commun
immunis
clinic
enrol
children
attend
clinic
respiratori
symptom
follow
recent
respiratori
ill
previous
enrol
case
control
elig
control
enrol
concurr
case
throughout
studi
period
target
enrol
four
age
group
year
year
year
year
frequencymatch
number
case
enrol
preced
week
sampl
size
calcul
studi
previous
structur
questionnair
administ
parentsguardian
captur
demographi
relev
comorbid
includ
immunodefici
immunocompromis
condit
congenit
chromosom
abnorm
chronic
respiratori
neuromuscular
neurolog
cardiac
diseas
solid
organ
transplant
flock
nasopharyng
swab
floqswab
copan
diagnost
murrieta
california
usa
collect
particip
train
research
assist
case
swab
collect
hour
hospit
present
collect
swab
place
immedi
ml
ice
specimen
store
prior
nucleic
acid
extract
total
virus
influenza
influenza
b
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
hpiv
type
human
metapneumoviru
hmpv
adenoviru
rhinoviru
rv
human
coronaviru
hcov
type
bacteria
pneumonia
staphylococcu
aureu
moraxella
catarrhali
h
influenza
mycoplasma
pneumonia
chlamydophila
pneumonia
detect
use
polymeras
chain
reaction
pcr
detail
procedur
laboratori
test
nucleic
acid
extract
primer
probe
use
pcr
describ
rv
genotyp
done
follow
publish
molecular
crude
odd
ratio
exposur
calcul
assess
rel
frequenc
detect
respiratori
pathogen
among
case
control
multivari
logist
regress
use
calcul
adjust
aor
detect
pathogen
case
versu
control
adjust
underli
demograph
differ
recent
exposur
antibiot
presenc
pathogen
aor
pathogen
use
estim
populationattribut
fraction
paf
analys
perform
use
stata
softwar
figur
produc
use
graphpad
prism
version
graphpad
softwar
california
usa
written
inform
consent
obtain
parentsleg
guardian
studi
particip
assent
obtain
particip
year
old
enrol
children
pneumonia
control
case
case
diagnos
parapneumon
effus
parapneumonia
effus
drain
drain
effus
microscop
purul
consist
empyema
case
hospitalis
median
day
iqr
death
observ
compar
control
higher
proport
case
aborigin
born
prematur
report
smoker
household
p
tabl
proport
respond
year
attend
day
care
among
case
among
control
median
day
attend
per
week
case
day
iqr
control
day
iqr
higher
proport
case
comorbid
compar
control
vs
p
case
control
antibiot
day
prior
enrol
vs
p
proport
case
control
receiv
least
two
dose
pcv
respect
case
control
receiv
influenza
vaccin
preced
influenza
season
case
control
one
respiratori
virus
identifi
respect
ci
least
one
bacteri
speci
detect
respect
ci
distribut
respiratori
virus
bacteria
among
case
control
summaris
tabl
detect
virus
bacteria
observ
case
control
case
like
control
multipl
two
virus
detect
ci
multipl
bacteri
speci
ci
multivari
logist
regress
show
adjust
demograph
differ
antibiot
exposur
preced
day
presenc
pathogen
rsv
hmpv
influenza
viru
adenoviru
detect
significantli
often
among
case
control
aor
ci
ci
ci
ci
respect
tabl
none
influenzaposit
case
control
receiv
influenza
vaccin
preced
influenza
season
rv
speciat
avail
posit
sampl
case
control
rva
detect
case
control
rvb
case
control
rvc
detect
case
control
respiratori
virus
detect
commonli
among
children
year
compar
age
group
figur
case
posit
rsv
hpiv
hmpv
adenoviru
age
less
year
respiratori
virus
detect
throughout
year
frequent
detect
australian
winter
month
june
august
rv
detect
throughout
year
rsv
influenza
hmpv
mostli
detect
may
novemb
hpiv
decemb
april
viru
distribut
among
case
control
children
similar
along
year
calendar
figur
multivari
logist
regress
show
pneumonia
detect
significantli
often
among
case
control
aor
ci
frequenc
detect
bacteria
similar
among
case
control
tabl
nineteen
case
pneumonia
detect
prior
antibiot
exposur
compar
control
h
influenza
proport
case
control
catarrhali
case
control
aureu
case
control
pneumonia
case
control
given
potenti
antibiot
influenc
detect
bacteri
pathogen
analysi
repeat
includ
prior
antibiot
exposur
apart
pneumonia
aor
ci
signific
differ
pneumonia
aor
ci
h
influenza
aor
ci
catarrhali
aor
ci
aureu
aor
ci
detect
note
among
children
prior
antibiot
exposur
differ
note
agegroup
distribut
bacteri
detect
figur
among
infant
age
year
case
control
posit
pneumonia
vs
pneumonia
detect
commonli
schoolag
children
younger
children
catarrhali
detect
throughout
year
wherea
pneumonia
h
influenza
aureu
pneumonia
detect
commonli
winter
month
figur
estim
detect
respiratori
virus
respons
ci
childhood
pneumonia
western
australia
tabl
rsv
contribut
nearli
half
burden
ci
hmpv
contribut
ci
influenza
ci
adenoviru
ci
detect
bacteria
could
shown
make
signific
contribut
childhood
pneumonia
popul
pneumonia
ci
suffici
power
estim
age
groupspecif
paf
pathogen
respiratori
virus
appear
contribut
significantli
childhood
pneumonia
western
australia
prospect
enrol
test
children
hospitalis
radiolog
confirm
pneumonia
contemporan
healthi
children
abl
assess
contribut
common
respiratori
virus
bacteria
pneumonia
adjust
background
preval
detect
children
without
pneumonia
estim
detect
respiratori
virus
contribut
approxim
childhood
pneumonia
requir
hospitalis
respiratori
virus
detect
nasopharynx
children
pneumonia
compar
frequenc
viru
detect
paediatr
pneumonia
similar
previou
studi
also
abl
detect
respiratori
virus
nasopharynx
nearli
onethird
anoth
match
studi
virus
detect
frequent
case
control
studi
enrol
children
winter
month
respiratori
viru
circul
like
rsv
frequent
detect
viru
children
pneumonia
common
children
year
proport
children
pneumonia
rsv
detect
consist
report
previou
contrast
control
children
studi
rsv
posit
also
consist
publish
anoth
member
paramyxovirida
famili
hmpv
detect
case
infrequ
detect
healthi
control
high
adjust
detect
rsv
hmpv
children
pneumonia
strongli
implic
virus
probabl
pneumoniacaus
pathogen
rsv
well
establish
major
caus
lower
respiratori
tract
studi
add
grow
evid
hmpv
also
import
respiratori
pathogen
young
children
pneumonia
also
like
influenza
detect
influenza
well
document
caus
sever
occasion
fatal
respiratori
influenzaposit
case
control
unvaccin
low
influenza
vaccin
report
among
children
influenzaconfirm
pneumonia
consist
protect
effect
improv
uptak
season
influenza
vaccin
children
like
reduc
hospitalis
pneumonia
rv
detect
similar
proport
children
without
pneumonia
previou
studi
also
detect
rv
children
well
appar
asymptomat
latter
rais
doubt
contribut
rv
find
line
studi
also
fail
show
signific
contribut
rv
acut
respiratori
infect
rv
particularli
rvc
associ
childhood
wheez
role
childhood
pneumonia
establish
insuffici
number
determin
specif
rv
type
preval
among
case
control
studi
among
burundian
children
lower
respiratori
tract
symptom
associ
rva
pneumonia
rvc
howev
recent
use
advanc
molecular
techniqu
transcriptom
analysi
robust
immun
respons
measur
symptomat
children
detect
rv
substanti
higher
asymptomat
rvposit
suggest
role
rv
acut
respiratori
infect
need
explor
pneumonia
detect
similar
frequenc
among
case
report
previou
pneumonia
studi
particularli
preval
among
schoolag
children
unlik
pneumonia
identifi
infrequ
nasopharynx
control
pneumonia
frequent
caus
nonsever
atyp
pneumonia
detect
pneumonia
nasopharynx
report
asymptomat
children
make
difficult
interpret
clinic
role
pneumonia
moreov
conflict
inconclus
report
appropri
treatment
pneumonia
recent
review
metaanalysi
conclud
insuffici
evid
efficaci
singl
combin
multipl
antibiot
lower
respiratori
tract
infect
children
associ
pneumonia
h
influenza
catarrhali
detect
similar
frequenc
children
without
pneumonia
howev
high
vaccin
coverag
almost
elimin
pathogen
vaccinetyp
strain
pneumonia
h
influenza
differ
overal
pneumonia
detect
frequent
among
infant
pneumonia
control
infant
suggest
pneumonia
may
remain
import
caus
pneumonia
earli
life
result
suggest
lesser
contribut
bacteria
childhood
pneumonia
virus
caution
disprov
import
role
bacteria
plausibl
exampl
secondari
bacteri
infect
play
import
role
mani
case
viral
major
strength
studi
contemporan
enrol
children
without
pneumonia
frequencymatch
age
pneumonia
case
throughout
studi
period
address
methodolog
limit
previou
studi
develop
set
post
pneumococc
vaccin
howev
studi
limit
detect
respiratori
virus
bacteria
collect
biolog
specimen
upper
respiratori
tract
nasopharynx
diagnosi
probabl
infecti
agent
associ
lower
respiratori
tract
ill
pneumonia
children
often
base
minim
invas
nasopharyng
aspir
nosethroat
test
specimen
usual
steril
site
includ
blood
pleural
fluid
cultur
pcr
avail
set
mandat
protocol
note
detect
pathogen
upper
respiratori
tract
conclus
causal
associ
diseas
howev
test
control
children
without
pneumonia
enabl
us
better
estim
contribut
pneumonia
popul
level
abil
identifi
respiratori
pathogen
associ
pneumonia
limit
sensit
test
specimen
nasopharynx
infect
lower
airway
differ
pathogen
detect
upper
lower
tract
shown
plausibl
case
detect
viru
shed
viru
nasopharynx
might
insignific
shed
might
wane
time
children
hospitalis
pneumonia
sensit
test
method
like
incomplet
expect
estim
contribut
virus
pneumonia
repres
minimum
estim
use
qualit
pcr
assay
studi
determin
pathogen
densiti
quantit
assay
may
permit
distinct
caus
coincident
infect
particular
case
collect
data
radiograph
detail
exampl
lobar
consolid
intestin
infiltr
enrol
case
would
use
assess
radiograph
pattern
associ
pathogen
bacteri
viral
detect
nasopharynx
burden
childhood
pneumonia
could
reduc
effect
vaccin
treatment
target
virus
readili
understand
contribut
viru
pneumonia
import
inform
prioritis
vaccin
develop
australia
wellestablish
health
infrastructur
high
rate
vaccin
coverag
find
studi
expect
generalis
similar
develop
set
necessarili
resourcepoor
set
countri
high
crowd
differ
social
mix
pattern
low
vaccin
coverag
nonetheless
note
data
compar
data
studi
highincom
middl
lowincom
comprehens
studi
describ
contribut
respiratori
pathogen
childhood
pneumonia
australia
date
one
studi
childhood
pneumonia
highincom
set
pcv
era
found
respiratori
virus
major
contributor
childhood
pneumonia
rsv
appear
account
substanti
proport
viral
pneumonia
continu
focu
develop
prevent
treatment
strategi
burden
hmpv
pneumonia
may
underappreci
data
studi
could
serv
baselin
characterist
assess
effect
viral
vaccin
avail
futur
studi
aim
develop
precis
diagnost
tool
reliabl
distinguish
viral
bacteri
pneumonia
allow
target
antivir
therapi
judici
use
antibiot
treat
childhood
pneumonia
